SALTO - Symbicort Single Inhaler Therapy Use in Adolescent Adults and Adults With Persistent Asthma
Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
The primary objective is to compare the efficacy of Symbicort Single inhaler Therapy with
treatment according to conventional best practice in adolescent and adult patients with
persistent asthma.
Phase:
Phase 3
Details
Lead Sponsor:
AstraZeneca
Treatments:
Budesonide Budesonide, Formoterol Fumarate Drug Combination Formoterol Fumarate